Literature DB >> 26316320

Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia.

I Antony-Debré1,2, N Duployez3,4, M Bucci3, S Geffroy3,4, J-B Micol2,5,6, A Renneville3,4, N Boissel7, N Dhédin7, D Réa7, B Nelken8, C Berthon4,9, T Leblanc10, M-J Mozziconacci11, R Favier2,12, P G Heller13, O Abdel-Wahab5, H Raslova2, V Latger-Cannard14, C Preudhomme3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26316320     DOI： 10.1038/leu.2015.236

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Recurrent CDC25C mutations drive malignant transformation in FPD/AML.

Authors:  Akihide Yoshimi; Takashi Toya; Masahito Kawazu; Toshihide Ueno; Ayato Tsukamoto; Hiromitsu Iizuka; Masahiro Nakagawa; Yasuhito Nannya; Shunya Arai; Hironori Harada; Kensuke Usuki; Yasuhide Hayashi; Etsuro Ito; Keita Kirito; Hideaki Nakajima; Motoshi Ichikawa; Hiroyuki Mano; Mineo Kurokawa
Journal:  Nat Commun       Date:  2014-08-27       Impact factor: 14.919

2.  Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia.

Authors:  Dominique Bluteau; Laure Gilles; Morgane Hilpert; Iléana Antony-Debré; Chloe James; Najet Debili; Valerie Camara-Clayette; Orianne Wagner-Ballon; Veronique Cordette-Lagarde; Thomas Robert; Hugues Ripoche; Patrick Gonin; Sabina Swierczek; Josef Prchal; William Vainchenker; Remi Favier; Hana Raslova
Journal:  Blood       Date:  2011-07-01       Impact factor: 22.113

Review 3.  Familial myelodysplastic syndromes: a review of the literature.

Authors:  Elena Liew; Carolyn Owen
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

4.  Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).

Authors:  N Boissel; H Leroy; B Brethon; N Philippe; S de Botton; A Auvrignon; E Raffoux; T Leblanc; X Thomas; O Hermine; B Quesnel; A Baruchel; G Leverger; H Dombret; C Preudhomme
Journal:  Leukemia       Date:  2006-06       Impact factor: 11.528

5.  Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.

Authors:  Paula G Heller; Ana C Glembotsky; Manish J Gandhi; Carrie L Cummings; Carlos J Pirola; Rosana F Marta; Laura I Kornblihtt; Jonathan G Drachman; Felisa C Molinas
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

6.  Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia.

Authors:  Iléana Antony-Debré; Vladimir T Manchev; Nathalie Balayn; Dominique Bluteau; Cécile Tomowiak; Céline Legrand; Thierry Langlois; Olivia Bawa; Lucie Tosca; Gérard Tachdjian; Bruno Leheup; Najet Debili; Isabelle Plo; Jason A Mills; Deborah L French; Mitchell J Weiss; Eric Solary; Remi Favier; William Vainchenker; Hana Raslova
Journal:  Blood       Date:  2014-12-09       Impact factor: 22.113

7.  Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.

Authors:  Thomas Pabst; Marianne Eyholzer; Simon Haefliger; Julian Schardt; Beatrice U Mueller
Journal:  J Clin Oncol       Date:  2008-09-02       Impact factor: 44.544

8.  Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions.

Authors:  Mylène Béri-Dexheimer; Véronique Latger-Cannard; Christophe Philippe; Céline Bonnet; Pascal Chambon; Virginie Roth; Marie-José Grégoire; Pierre Bordigoni; Thomas Lecompte; Bruno Leheup; Philippe Jonveaux
Journal:  Eur J Hum Genet       Date:  2008-05-14       Impact factor: 4.246

9.  Concomitant germ-line RUNX1 and acquired ASXL1 mutations in a T-cell acute lymphoblastic leukemia.

Authors:  Thomas Prebet; Nadine Carbuccia; Hana Raslova; Rémi Favier; Jerome Rey; Christine Arnoulet; Norbert Vey; William Vainchenker; Daniel Birnbaum; Marie-Joelle Mozziconacci
Journal:  Eur J Haematol       Date:  2013-06-28       Impact factor: 3.674

10.  RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group.

Authors:  Verena I Gaidzik; Lars Bullinger; Richard F Schlenk; Andreas S Zimmermann; Jürgen Röck; Peter Paschka; Andrea Corbacioglu; Jürgen Krauter; Brigitte Schlegelberger; Arnold Ganser; Daniela Späth; Andrea Kündgen; Ingo G H Schmidt-Wolf; Katharina Götze; David Nachbaur; Michael Pfreundschuh; Heinz A Horst; Hartmut Döhner; Konstanze Döhner
Journal:  J Clin Oncol       Date:  2011-02-22       Impact factor: 50.717
View more
  30 in total

Review 1.  The Emerging Role of Hematopathologists and Molecular Pathologists in Detection, Monitoring, and Management of Myeloid Neoplasms with Germline Predisposition.

Authors:  Rashmi Kanagal-Shamanna
Journal:  Curr Hematol Malig Rep       Date:  2021-05-24       Impact factor: 3.952

Review 2.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

Review 3.  The contribution of mouse models to the understanding of constitutional thrombocytopenia.

Authors:  Catherine Léon; Arnaud Dupuis; Christian Gachet; François Lanza
Journal:  Haematologica       Date:  2016-08       Impact factor: 9.941

Review 4.  Myeloid neoplasms with germ line RUNX1 mutation.

Authors:  Yoshihiro Hayashi; Yuka Harada; Gang Huang; Hironori Harada
Journal:  Int J Hematol       Date:  2017-05-22       Impact factor: 2.490

Review 5.  Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).

Authors:  Anna L Brown; Christopher N Hahn; Hamish S Scott
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

6.  Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigree.

Authors:  Kiran Tawana; Jun Wang; Péter A Király; Krisztián Kállay; Gábor Benyó; Marianna Zombori; Judit Csomor; Ahad Al Seraihi; Ana Rio-Machin; András Matolcsy; Claude Chelala; Jamie Cavenagh; Jude Fitzgibbon; Csaba Bödör
Journal:  Eur J Hum Genet       Date:  2017-05-17       Impact factor: 4.246

Review 7.  Transcription factor mutations as a cause of familial myeloid neoplasms.

Authors:  Jane E Churpek; Emery H Bresnick
Journal:  J Clin Invest       Date:  2019-02-01       Impact factor: 14.808

Review 8.  Significance of Clonal Mutations in Bone Marrow Failure and Inherited Myelodysplastic Syndrome/Acute Myeloid Leukemia Predisposition Syndromes.

Authors:  Eva J Schaefer; R Coleman Lindsley
Journal:  Hematol Oncol Clin North Am       Date:  2018-05-01       Impact factor: 3.722

9.  RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.

Authors:  Anna L Brown; Peer Arts; Catherine L Carmichael; Milena Babic; Julia Dobbins; Chan-Eng Chong; Andreas W Schreiber; Jinghua Feng; Kerry Phillips; Paul P S Wang; Thuong Ha; Claire C Homan; Sarah L King-Smith; Lesley Rawlings; Cassandra Vakulin; Andrew Dubowsky; Jessica Burdett; Sarah Moore; Grace McKavanagh; Denae Henry; Amanda Wells; Belinda Mercorella; Mario Nicola; Jeffrey Suttle; Ella Wilkins; Xiao-Chun Li; Joelle Michaud; Peter Brautigan; Ping Cannon; Meryl Altree; Louise Jaensch; Miriam Fine; Carolyn Butcher; Richard J D'Andrea; Ian D Lewis; Devendra K Hiwase; Elli Papaemmanuil; Marshall S Horwitz; Georges Natsoulis; Hugh Y Rienhoff; Nigel Patton; Sally Mapp; Rachel Susman; Susan Morgan; Julian Cooney; Mark Currie; Uday Popat; Tilmann Bochtler; Shai Izraeli; Kenneth Bradstock; Lucy A Godley; Alwin Krämer; Stefan Fröhling; Andrew H Wei; Cecily Forsyth; Helen Mar Fan; Nicola K Poplawski; Christopher N Hahn; Hamish S Scott
Journal:  Blood Adv       Date:  2020-03-24

10.  Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia.

Authors:  Yizhen Li; Wentao Yang; Meenakshi Devidas; Stuart S Winter; Chimene Kesserwan; Wenjian Yang; Kimberly P Dunsmore; Colton Smith; Maoxiang Qian; Xujie Zhao; Ranran Zhang; Julie M Gastier-Foster; Elizabeth A Raetz; William L Carroll; Chunliang Li; Paul P Liu; Karen R Rabin; Takaomi Sanda; Charles G Mullighan; Kim E Nichols; William E Evans; Ching-Hon Pui; Stephen P Hunger; David T Teachey; Mary V Relling; Mignon L Loh; Jun J Yang
Journal:  J Clin Invest       Date:  2021-06-24       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.